Demyelination in a patient receiving ustekinumab for refractory Crohn's disease

J Crohns Colitis. 2014 Sep;8(9):1138-9. doi: 10.1016/j.crohns.2014.02.004. Epub 2014 Feb 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Crohn Disease / diagnosis
  • Crohn Disease / drug therapy*
  • Demyelinating Diseases / chemically induced*
  • Demyelinating Diseases / diagnosis
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Retrospective Studies
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Ustekinumab